287 related articles for article (PubMed ID: 11713089)
1. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors.
Shields CL; Shields JA; Cater J; Othmane I; Singh AD; Micaily B
Ophthalmology; 2001 Nov; 108(11):2116-21. PubMed ID: 11713089
[TBL] [Abstract][Full Text] [Related]
2. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
[TBL] [Abstract][Full Text] [Related]
3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
4. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
5. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
6. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
7. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
8. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
[TBL] [Abstract][Full Text] [Related]
9. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
10. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in the management of retinoblastoma.
Shields CL; Shields JA
J Pediatr Ophthalmol Strabismus; 1999; 36(1):8-18; quiz 35-6. PubMed ID: 9972509
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients.
Dalvin LA; Bas Z; Tadepalli S; Rao R; Vaidya S; Pacheco R; Shields CL
J Pediatr Ophthalmol Strabismus; 2020 Jul; 57(4):224-234. PubMed ID: 32687206
[TBL] [Abstract][Full Text] [Related]
13. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
[TBL] [Abstract][Full Text] [Related]
14. Continuing challenges in the management of retinoblastoma with chemotherapy.
Shields CL; Meadows AT; Leahey AM; Shields JA
Retina; 2004 Dec; 24(6):849-62. PubMed ID: 15579981
[TBL] [Abstract][Full Text] [Related]
15. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment.
Shields CL; Shields JA; De Potter P; Minelli S; Hernandez C; Brady LW; Cater JR
Ophthalmology; 1993 Feb; 100(2):216-24. PubMed ID: 8437830
[TBL] [Abstract][Full Text] [Related]
16. Chemoreduction in the initial management of intraocular retinoblastoma.
Shields CL; De Potter P; Himelstein BP; Shields JA; Meadows AT; Maris JM
Arch Ophthalmol; 1996 Nov; 114(11):1330-8. PubMed ID: 8906023
[TBL] [Abstract][Full Text] [Related]
17. Thermotherapy for retinoblastoma.
Shields CL; Santos MC; Diniz W; Gündüz K; Mercado G; Cater JR; Shields JA
Arch Ophthalmol; 1999 Jul; 117(7):885-93. PubMed ID: 10408452
[TBL] [Abstract][Full Text] [Related]
18. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
[TBL] [Abstract][Full Text] [Related]
19. Globe conserving treatment of the only eye in bilateral retinoblastoma.
Lee V; Hungerford JL; Bunce C; Ahmed F; Kingston JE; Plowman PN
Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838
[TBL] [Abstract][Full Text] [Related]
20. Iodine-125 Plaque Radiotherapy for Retinoblastoma Recurrence Following Intra-arterial Chemotherapy.
Ruben M; Eiger-Moscovich M; Yaghy A; Tadepalli S; Shields CL
J Pediatr Ophthalmol Strabismus; 2022; 59(3):164-171. PubMed ID: 34928770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]